Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns

被引:2
|
作者
Samuel, Sonia [1 ]
Michael, Mark [1 ]
Tadros, Micheal [2 ]
机构
[1] Albany Med Ctr, Dept Internal Med, Albany, NY 12208 USA
[2] Albany Med Ctr, Dept Gastroenterol & Hepatol, 43 New Scotland Ave, Albany, NY 12208 USA
关键词
Marijuana; cannabis; Endocannabinoid system; Side effects; Gastrointestinal disorders; ESOPHAGEAL SPHINCTER RELAXATIONS; INDUCED ACUTE-PANCREATITIS; IRRITABLE-BOWEL-SYNDROME; BODY-MASS INDEX; CROHNS-DISEASE; DOUBLE-BLIND; MARIJUANA USE; COMBINATION THERAPY; ANXIETY DISORDERS; MEGESTROL-ACETATE;
D O I
10.12998/wjcc.v11.i18.4210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cannabis, commonly known as marijuana, is a drug extracted from the Cannabis plant known for its psychotropic and medicinal properties. It has been used for healing purposes during ancient times, although its psychoactive components led to its restricted use in medicine. Nonetheless, cannabis is found to have modulatory effects on the endocannabinoid system exhibiting its medicinal role in the gastrointestinal (GI) system. Emerging animal and human studies demonstrate the influential effects of cannabis on a variety of GI diseases including inflammatory bowel disease, motility disorders and GI malignancies. It also has a regulatory role in GI symptoms including nausea and vomiting, anorexia, weight gain, abdominal pain, among others. However, both its acute and chronic use can lead to undesirable side effects such as dependency and addiction, cognitive impairment and cannabinoid hyperemesis syndrome. We will discuss the role of cannabis in the GI system as well as dosing strategies to help guide gastroenterologists to assess its efficacy and provide patient counseling before prescription of medical marijuana.
引用
收藏
页数:22
相关论文
共 47 条
  • [21] Should Cannabis be Used for Anorexia in Patients With Cancer?
    Davis, Mellar
    Cyr, Claude
    Crawford, Gregory B.
    Case, Amy A.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : e487 - e492
  • [22] Gastroenterologists' Attitude Regarding Medical Cannabis for Inflammatory Bowel Diseases in Israel
    Koslowsky, Benjamin
    Mazuz, Betty
    Ben-Ya'acov, Ami
    Neumark, Aliza
    Shitrit, Ariella Bar-Gil
    Goldin, Eran
    DIGESTIVE DISEASES, 2021, 39 (05) : 502 - 507
  • [23] Should Oncologists Recommend Cannabis?
    Donald I. Abrams
    Current Treatment Options in Oncology, 2019, 20
  • [24] Practical Considerations for the Use of Cannabis in Cancer Pain Management-What a Medical Oncologist Should Know
    Gorzo, Alecsandra
    Havasi, Andrei
    Spinu, Stefan
    Oprea, Adela
    Burz, Claudia
    Sur, Daniel
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [25] Implications of the 2018 Canadian Cannabis Act: Should regulation differ for medicinal and non-medicinal cannabis use?
    Cox, Chelsea
    HEALTH POLICY, 2021, 125 (01) : 12 - 16
  • [26] The lows of getting high: sentinel surveillance of injuries associated with cannabis and other substance use
    Deepa P. Rao
    Hanan Abramovici
    Jennifer Crain
    Minh T. Do
    Steven McFaull
    Wendy Thompson
    Canadian Journal of Public Health, 2018, 109 : 155 - 163
  • [27] Pharmacologic therapy for Peyronie's disease: what should we prescribe?
    Sherer, Benjamin A.
    Godlewski, Karl F.
    Levine, Laurence A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (09) : 1299 - 1311
  • [28] Cannabis for Inflammatory Bowel Diseases: Should We Follow the Wisdom of the Crowd?
    Naftali, Timna
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (11): : 756 - 758
  • [29] Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy
    Kane, Sunanda V.
    Acquah, Letitia A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (01) : 228 - 233
  • [30] Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?
    Bolland, M. J.
    Grey, A.
    Reid, I. R.
    CLIMACTERIC, 2015, 18 : 22 - 31